Physician profile
Gary M Felhandler
NPI 1043499338
$179.06
in general payments reported to CMS, 2019-2025
9 companies · $69.94 in 2025
The $69.94 reported for 2025 was less than what a typical Podiatrist provider received nationally (typical 2025 total: $260).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $10.77 · 2021: $12.20 · 2022: $38.20 · 2023: $15.59 · 2024: $32.36 · 2025: $69.94.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $118.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $117.89 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $31.21 | 2025 | Nuzyra |
| Organogenesis INC. | $29.00 | 2022-2023 | Puraply |
| Kerecis Limited | $24.79 | 2022 | |
| Integra Lifesciences Corporation | $22.93 | 2025 | Integra, Integra Dermal Regeneration Template, Primatrix |
| Bioventus LLC | $16.81 | 2024 | Exogen Ultrasound Bone Healing System |
| Smith+Nephew, INC. | $15.80 | 2025 | Grafix Pl |
| Nevro Corp. | $15.55 | 2024 | Senza |
| Horizon Therapeutics Plc | $12.20 | 2021 | |
| Arthrosurface Incorporated | $10.77 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Gary Felhandler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.